J+D FORECASTING LAUNCHES INNOVATIVE ONCOLOGY FORECASTING SOFTWARE

5th July 2019
J+D Forecasting, one of the world’s leading pharmaceutical forecasting companies, has today announced the launch of Onco+, as the latest addition to its comprehensive suite of forecasting software.
Read More

J+D Forecasting at ASCO 2019

30th May 2019
ASCO 2019  With a theme of Caring for Every Patient, Learning from Every Patient, 2019 was another record-breaking year for ASCO® with over 42,000 total attendees.   Advances in targeted therapies for pancreatic, prostate, and paediatric cancers, as well as new approaches to overcoming limited access to cancer…
Read More

Something beautiful in forecasting is about to happen

2nd July 2018
Introducing FC+ J+D Forecasting are very proud to announce the launch of their latest pharmaceutical forecasting innovation, FC+. Developed by J+D software experts, FC+ is set to disrupt the way pharma and biotech companies approach forecasting. A significant advancement in forecasting Say goodbye to the…
Read More

J+D delivers impactful forecasting training at EphMRA 2016 Conference

17th July 2016
We were delighted to be a part of EphMRA’s Flagship Annual Conference this year in Frankfurt. As a thought leader in Forecasting, David James (CEO of J+D) is always pleased to offer advice and support to others in the Pharma Industry regarding the importance of…
Read More

The Fundamental Pillars that Support Good Forecasting

21st June 2017
The Context Here at J+D we create 100’s of strategic forecasting and operational planning models for many of the largest pharmaceutical companies year on year. These figures have increased consistently, certainly in the last 5-7 years; as scrutiny from pharmaceutical investors puts increasing pressure on revenue…
Read More